{"id":"tdcp-ipv-vaccine","safety":{"commonSideEffects":[{"rate":"null","effect":"Pain, redness, or swelling at the injection site"}]},"_chembl":{"chemblId":"CHEMBL2108573","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It achieves this by introducing inactivated poliovirus and tetanus toxoid antigens to the body, which triggers the production of antibodies and immune cells to fight these pathogens. This process helps build immunity and prevent future infections.","oneSentence":"The TdcP-IPV vaccine works by stimulating an immune response to protect against certain diseases.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:37:36.992Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Diphtheria, tetanus, and poliomyelitis prevention"}]},"trialDetails":[{"nctId":"NCT02040636","phase":"PHASE2","title":"Study of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated Poliomyelitis","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"1999-01","conditions":"Pertussis, Tetanus, Diphtheria","enrollment":277},{"nctId":"NCT00797511","phase":"PHASE3","title":"Immunogenicity and Safety of Adacel Polio Vaccine","status":"COMPLETED","sponsor":"Sanofi","startDate":"2008-11","conditions":"Diphtheria, Tetanus, Pertussis","enrollment":132}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["ADACEL POLIO"],"phase":"phase_3","status":"active","brandName":"TdcP-IPV vaccine","genericName":"TdcP-IPV vaccine","companyName":"Sanofi","companyId":"sanofi","modality":"Biologic","firstApprovalDate":"","aiSummary":"The TdcP-IPV vaccine works by stimulating an immune response to protect against certain diseases. Used for Diphtheria, tetanus, and poliomyelitis prevention.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}